Isolation of a porcine intestinal peptide with C-terminal somatostatin

doi:10.1016/0006-291X(78)91218-4

Biochemical and Biophysical Research Communications

Volume 85, Issue 2, 29 November 1978, Pages 701-708

https://doi.org/10.1016/0006-291X(78)91218-4 Get rights and content

Abstract

A peptide showing somatostatin-like immunoreactivity has been isolated from acid extracts of porcine upper small intestine. Purification was followed by radioimmunoassay, high pressure liquid chromatography, thin layer chromatography and isotachophoresis. Preliminary chemical characterization shows that it has N-terminal serine and that it is composed of somatostatin extended from its N-terminus by an additional peptide.

References (19)

W. Vale et al.
Metabolism
(1976)
J.A. Chayvialle et al.
Gastroenterology
(1978)
K.R. Woods et al.
Biochim. Biophys. Acta
(1967)
S. Moore
J. Biol. Chem
(1963)
P. Brazeau et al.
Can. J. Biochem
(1974)
R. Burgus et al.
A.V. Schally et al.
Biochem
(1976)
W. Vale et al.
Rec. Prog. Horm. Res
(1975)
M. Broenstein et al.
Endocrinol
(1975)

There are more references available in the full text version of this article.

Cited by (60)

Gastrointestinal Hormones
2018, Physiology of the Gastrointestinal Tract, Sixth Edition
Gut peptides are key signaling molecules for the feedback control of gastrointestinal function and the coordination of central and peripheral responses to nutrient ingestion. Peptides are implicated in roles as diverse as control of gastric, biliary and pancreatic secretion, intestinal motility, insulin and glucagon secretion, and the central sensations of hunger and satiety. This chapter reviews the synthesis, structure, and function of key gastrointestinal peptides and the two key signaling amines 5-HT and histamine.
Somatostatin, Alzheimer's disease and cognition: An old story coming of age?
2009, Progress in Neurobiology
In mammalian brain, the somatostatin (SRIF: somatotropin release-inhibiting factor) family is composed of two peptides: SRIF and cortistatin (CST), which interact with five different receptor subtypes, sst_1–5. This review summarizes the properties of these receptors, the involvement of somatostatinergic systems in Alzheimer's disease (SRIF/acetylcholine (Ach), SRIF/amyloid β peptides, and SRIF/tau interactions) and their role in cognition from early studies using cysteamine as an SRIF depleting substance to the use of subtype selective analogues and knockout mice, and modulation of synaptic plasticity. The current SRIF story illustrates how cognition and emotion are intimately integrated in brain function.
The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review
2009, Regulatory Peptides
Extensive functional and morphological research has demonstrated the pivotal role of somatostatin (SOM) in the regulation of a wide variety of gastrointestinal activities. In addition to its profound inhibitory effects on gastrointestinal motility and exocrine and endocrine secretion processes along the entire gastrointestinal tract, SOM modulates several organ-specific activities. In contrast to these well-known SOM-dependent effects, knowledge on the SOM receptors (SSTR) involved in these effects is much less conclusive. Experimental data on the identities of the SSTRs, although species- and tissue-dependent, point towards the involvement of multiple receptor subtypes in the vast majority of gastrointestinal SOM-mediated effects. Recent evidence demonstrating the role of SOM in intestinal pathologies has extended the interest of gastrointestinal research in this peptide even further. More specifically, SOM is supposed to suppress intestinal inflammatory responses by interfering with the extensive bidirectional communication between mucosal mast cells and neurons. This way, SOM not only acts as a powerful inhibitor of the inflammatory cascade at the site of inflammation, but exerts a profound antinociceptive effect through the modulation of extrinsic afferent nerve fibres. The combination of these physiological and pathological activities opens up new opportunities to explore the potential of stable SOM analogues in the treatment of GI inflammatory pathologies.
Rapid analysis of somatostatin in pharmaceutical preparations by HPLC with a micropellicular reversed-phase column
1994, Journal of Pharmaceutical and Biomedical Analysis
A rapid high-performance liquid chromatography method for the analysis of somatostatin in pharmaceutical preparations is described. A commercially available column packed with 2 μm spherical non-porous silica-based reversed-phase sorbent is used, along with a mobile phase consisting of acetonitrile and aqueous phosphoric acid, adjusted to pH 2.8 with sodium hydroxide. The effect of the organic modifier content and column temperature on the retention behaviour of somatostatin is reported. The method is found to be highly selective and specific, as indicated by the baseline separation of a mixture containing somatostatin and two analogue peptides, which differ from the analyte for one and two amino acids, respectively. Down to 10 ng of somatostatin can be detected and the detector response is linear over the concentration range from 4.14 to 20.75 μg ml⁻¹. The application of this method to two commercial pharmaceutical formulations of somatostatin is found to give a mean percentage recovery from each of the two commercial samples, subjected to multiple injection analysis (n = 5), of 100.9% with a RSD of 0.92%, and 102.6% with a RSD of 1.56%, respectively.
Immunohistochemical localization of different forms of somatostatin in the gastrointestinal tract of the calf
1994, Acta Histochemica
The presence of two peptides that belong to the somatostatin family has been investigated in the calf gut. Somatostatin-14-like and Somatostatin-28-like peptides have been localized by a light microscopic immunohistochemical method. The method employed antibodies linked to colloidal gold particles that were revealed by a silver-enhancement step. Somatostatin-14-like peptide was only present in mucosal endocrine cells, which were detectable along the entire gut with the exceptions of the abomasal gastric proper glands and caecum. The cells were most abundant in cardiac and pyloric glands. Langerhans' islets also contained this type of endocrine cell. Somatostatin-28-like-immunoreactive endocrine cells were more abundant than the former cell type. They were present in the gastric proper glands and caecum where Somatostatin-14-like-immunoreactive cells were absent. They were as numerous as the former type of cell in the endocrine pancreas. The Somatostatin-28-like peptide was also detectable in the intramural nervous components of the abomasum and the intestine, in both perikarya and terminals. Our results show a possible heterogeneity of an endocrine cell type, which synthesizes and secretes somatostatin peptides. Our results also support the hypothesis that somatostatin-14 and somatostatin-28 peptides may have distinct functional roles, particularly in different species.
Light and electron microscopic immunocytochemical demonstration of the coexistence of somatostatin 14- and somatostatin 25-like peptides in endocrine cells of the stomach of Sparus aurata (teleost)
1991, General and Comparative Endocrinology
An immunofluorescence double-staining method colocalized somatostatin 14 (SST 14)- and somatostatin 25 (SST 25)-like immunoreactivities in endocrine cells located in the depth of gastric folds and upper part of the stomach glands of Sparus aurata (gilthead sea bream). An immunogold method identified somatostatin-like peptides in the secretory granules of the previously described Type IV endocrine cells. Appropriate preabsorption controls demonstrated two different granule populations with somatostatin-like immunoreactivity. SST 14-like peptides seemed to be located in the most commonly found granules, which showed a fibrillar content, whereas SST 25-like peptides were identified in more scarce and denser granules.

View all citing articles on Scopus

View full text

Isolation of a porcine intestinal peptide with C-terminal somatostatin

Abstract

Metabolism

Gastroenterology

Biochim. Biophys. Acta

J. Biol. Chem

Can. J. Biochem

Biochem

Rec. Prog. Horm. Res

Endocrinol